Basal Forebrain Volume, but Not Hippocampal Volume, Is a Predictor of Global Cognitive Decline in Patients With Alzheimer's Disease Treated With Cholinesterase Inhibitors

Background: Predicting the progression of cognitive decline in Alzheimer's disease (AD) is important for treatment selection and patient counseling. Structural MRI markers such as hippocampus or basal forebrain volumes might represent useful instruments for the prediction of cognitive decline....

Descripción completa

Detalles Bibliográficos
Autores principales: Teipel, Stefan J., Cavedo, Enrica, Hampel, Harald, Grothe, Michel J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104491/
https://www.ncbi.nlm.nih.gov/pubmed/30158893
http://dx.doi.org/10.3389/fneur.2018.00642

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6104491/
https://www.ncbi.nlm.nih.gov/pubmed/30158893
http://dx.doi.org/10.3389/fneur.2018.00642

Ejemplares similares